Breakthrough in diabetes.
It is the first treatment for type 1 diabetes prevention to receive approval. The US Food and Drug Administration (FDA) granted approval for the ground-breaking new medication Tzield on November 17, 2022. The combination of two medications in this injectable formulation may delay the onset of type 1 diabetes (T1D)...